Programming the magnitude and persistence of antibody responses with innate immunity

…, R Ravindran, S Stewart, M Alam, M Kwissa, F Villinger… - Nature, 2011 - nature.com
Many successful vaccines induce persistent antibody responses that can last a lifetime. The
mechanisms by which they do so remain unclear, but emerging evidence indicates that they …

[PDF][PDF] Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

…, TP Sheahan, KD Smith, DH Fuller, F Villinger… - Cell, 2021 - cell.com
Understanding vaccine-elicited protection against SARS-CoV-2 variants and other
sarbecoviruses is key for guiding public health policies. We show that a clinical stage multivalent …

[HTML][HTML] Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

…, D Montefiori, SD Boyd, JAL Flynn, G Alter, F Villinger… - Nature, 2021 - nature.com
The development of a portfolio of COVID-19 vaccines to vaccinate the global population
remains an urgent public health imperative 1 . Here we demonstrate the capacity of a subunit …

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

RR Amara, F Villinger, JD Altman, SL Lydy, SP O'Neil… - Science, 2001 - science.org
Heterologous prime/boost regimens have the potential for raising high levels of immune
responses. Here we report that DNA priming followed by a recombinant modified vaccinia …

Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity

…, J Fontenot, JC Love, DH Barouch, F Villinger… - Science translational …, 2022 - science.org
To combat the HIV epidemic and emerging threats such as SARS-CoV-2, immunization
strategies are needed that elicit protection at mucosal portals of pathogen entry. Immunization …

Late complications of immune deviation therapy in a nonhuman primate

CP Genain, K Abel, N Belmar, F Villinger… - Science, 1996 - science.org
The administration of antigens in soluble form can induce antigen-specific immune tolerance
and suppress experimental autoimmune diseases. In a marmoset model of multiple …

[HTML][HTML] Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine …

…, SD Boyd, RP Bohm, J Rappaport, F Villinger… - Cellular & molecular …, 2022 - nature.com
Although antivirals are important tools to control severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, effective vaccines are essential to control the current …

[HTML][HTML] The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?

PD Katsikis, YM Mueller, F Villinger - PLoS pathogens, 2011 - journals.plos.org
Cytokines play a central role in the pathogenesis of many diseases, including HIV infection.
However, the role of the cytokine network in early HIV infection is only now starting to be …

[HTML][HTML] A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and …

…, SK Bhaumik, MK Kaja, F Villinger… - PLoS neglected …, 2018 - journals.plos.org
Background Dengue is one of the fastest spreading vector-borne diseases, caused by four
antigenically distinct dengue viruses (DENVs). Antibodies against DENVs are responsible for …

[HTML][HTML] Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques

…, T Legere, YO Kovalenkov, CC Labranche, F Villinger… - JCI insight, 2019 - ncbi.nlm.nih.gov
Antibodies and cytotoxic T cells represent 2 arms of host defense against pathogens. We
hypothesized that vaccines that induce both high-magnitude CD8+ T cell responses and …